(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 4.83% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Elanco Animal Health's revenue in 2026 is $5,020,000,000.On average, 18 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,613,022,170,900, with the lowest ELAN revenue forecast at $2,498,109,150,000, and the highest ELAN revenue forecast at $2,713,446,158,730. On average, 18 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,753,415,905,130, with the lowest ELAN revenue forecast at $2,602,030,490,640, and the highest ELAN revenue forecast at $2,888,813,421,060.
In 2028, ELAN is forecast to generate $2,888,813,421,060 in revenue, with the lowest revenue forecast at $2,705,452,209,450 and the highest revenue forecast at $3,068,177,658,030.